Covidien releases RFID contrast delivery system

Covidien has released its contrast delivery system with radiofrequency identification (RFID) technology in the U.S.

The system combines its unit-dose, RFID-enabled Ultraject prefilled contrast media syringes with the company's RFID-enabled OptiVantage DH power injector, according to the Hamilton, Bermuda-based firm.

Related Reading

Covidien debuts Optistar Elite injector, July 17, 2008

Covidien names R&D team, July 2, 2008

Covidien acquires handheld injector technology, May 14, 2008

FDA clears Covidien RFID contrast system, May 8, 2008

Covidien posts strong Q2, May 7, 2008

Copyright © 2008 AuntMinnie.com

        An unexpected error occurred: Network error: Response not successful: Received status code 500
      
            [
  {
    "message": "Cannot execute GraphQL operations after the server has stopped.",
    "extensions": {
      "code": "INTERNAL_SERVER_ERROR"
    }
  }
]